Clinical Trials Logo
  1. Home
  2. Dyslipidaemia
  3. NCT00654602

48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety

Dyslipidaemia Clinical Trial

Official title:
A 48 Week, Open Label, Non-Comparative, Multicentre, Phase IIIb Study to Evaluate the Efficacy and Safety of the Lipid-Regulating Agent Rosuvastatin in the Treatment of Subjects With Fredrickson Type IIa and Type IIb Dyslipidaemia, Including Heterozygous Familial Hypercholesterolaemia.

Clinical Trial Summary

The purpose of this study is to assess the efficacy and safety of rosuvastatin in reducing low density lipoprotein cholesterol levels to internationally recognised goals in subjects with dyslipidaemia.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00654602
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 3
Start date February 2002
Completion date November 2004
View Details
See also
  Status Clinical Trial Phase
Completed NCT02230241 - CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II) N/A
Completed NCT04641299 - A Study of AZD8233 in Participants With Dyslipidemia Phase 2
Completed NCT01451918 - Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol Phase 2
Recruiting NCT01212328 - A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia N/A
Completed NCT01221584 - Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia N/A
Completed NCT00654225 - Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS) Phase 3
Withdrawn NCT02557412 - Effect of Nasal CPAP on Lipid Profile in Patients With Dyslipidaemia and Sleep Apnea N/A
Completed NCT00653965 - Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP) Phase 3
Recruiting NCT04442334 - The European NAFLD Registry
Completed NCT00653744 - Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES) Phase 3
Completed NCT01632358 - Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients Phase 1
Completed NCT02523391 - Bioequivalence Study of Capsule and Tablet Formulations of TA-8995 Phase 1
Completed NCT00474864 - Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. Phase 2
Completed NCT00659321 - Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome Phase 3
Completed NCT01055977 - Statin Therapy Results in the Real World Practice in the Czech Republic N/A
Recruiting NCT05979428 - A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood Phase 1
Completed NCT02241759 - Study of the Electrocardiographic Effects of TA-8995 Phase 1
Completed NCT00158899 - GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol Phase 2